Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

1999 • 3,357 citations

The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

1998 • 2,668 citations

Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

1995 • 1,374 citations

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease

1999 • 1,170 citations

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

1998 • 968 citations

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

1990 • 813 citations

Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

1998 • 772 citations

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

1999 • 748 citations

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

1998 • 699 citations

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

2000 • 618 citations

Proposals for immunological classification of acute leukemias.

1995 • 543 citations

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1998 • 467 citations

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1999 • 444 citations

Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients

1997 • 271 citations

Clinical significance of cytogenetics in acute myeloid leukemia.

1997 • 267 citations

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

1999 • 237 citations

Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic Leukemia

1999 • 219 citations

Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia

2000 • 196 citations

Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia

1995 • 173 citations

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.

1998 • 170 citations

Expression of unusual immunophenotype combinations in acute myelogenous leukemia

1993 • 168 citations

Expression of unusual immunophenotype combinations in acute myelogenous leukemia

1993 • 148 citations

Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.

1999 • 122 citations

Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB

2000 • 104 citations

Prediction of Relapse of Pediatric Acute Myeloid Leukemia by Use of Multidimensional Flow Cytometry

1996 • 87 citations

Characterization of aberrant phenotypes in acute myeloblastic leukemia

1995 • 87 citations

Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.

1995 • 77 citations

Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.

1996 • 74 citations

Textbook of Malignant Haematology

1999 • 55 citations

Immunophenotypical detection of minimal residual disease in acute leukemia

1999 • 50 citations

Neutralization of the Biological Activity of Erythropoietin by Immune Sera*

1964 • 16 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...